Mes de la Madre hasta 80% dcto  Ver más

menú

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment: Proceedings of the Symposium on New Drugs and Devices, Held at Philadelphi (en Inglés)
Formato
Libro Físico
Editorial
Idioma
Inglés
N° páginas
302
Encuadernación
Tapa Blanda
Dimensiones
23.4 x 15.6 x 1.7 cm
Peso
0.45 kg.
ISBN13
9781461338789

Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment: Proceedings of the Symposium on New Drugs and Devices, Held at Philadelphi (en Inglés)

Morganroth, J. ; Moore, E. Neil (Autor) · Springer · Tapa Blanda

Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment: Proceedings of the Symposium on New Drugs and Devices, Held at Philadelphi (en Inglés) - Morganroth, J. ; Moore, E. Neil

Libro Nuevo

$ 274.440

$ 381.170

Ahorras: $ 106.730

28% descuento
  • Estado: Nuevo
  • Quedan 95 unidades
Origen: Estados Unidos (Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el Jueves 18 de Julio y el Martes 30 de Julio.
Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment: Proceedings of the Symposium on New Drugs and Devices, Held at Philadelphi (en Inglés)"

In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Cardio-Renal Division of the Food and Drug Administration, academic investigators from the United States and Abroad and directors and imple- mentors of pharmacological research representing the pharmaceutical industry. By bringing together all three elements, it was hoped that better communication and under- standing would ensue to more rapidly bring new cardiac agents to the American public. This goal was important since a rather limited number of antiarrhythmic agents were and are currently available to treat patients with such disorders in the United States. These agents are needed not only for the treatment of patients with sustained ventricular tachyarrhythmias which produce life-threatening hemodynamic consequences but also and in fact more potentially important as a prophylactic measure in the high risk patient subject to sudden cardiac death. This book represents the proceedings of the third of these Symposiums whose purpose was to evaluate the clinical research methodology and models used in the evaluation of ne" antiarrhythmic agents for not only acute therapeutic inter- vention but also for the prophylaxis of sudden cardiac death. In addition, new devices have evolved over the past few years that can detect and treat life-threatening cardiac arrhythmias and the evaluation of efficacy and safety of these devices is detailed.

Opiniones del libro

Ver más opiniones de clientes
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Preguntas frecuentes sobre el libro

Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes